EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

High-density lipoproteins and the risk of atherosclerosis



High-density lipoproteins and the risk of atherosclerosis



New England Journal of Medicine 306(25): 1546-1548



While hypertension, cigarette smoking, and hyperlipidemia are all prominant risk factors for atherosclerosis (AS) (the most common lethal disease), AS develops in a small number of subjects without these factors. An alternate risk factor, decreased plasma high-density (alpha) lipoproproteins (HDL) levels (specifically, the cholesterol CH content of HDL) has been correlated with AS development. However, HDL also contains several apolipoporteins (ALP). The lack of ALP C-III is suggested as a major factor in premature AS, although its function is unknown. Present methods may be too insensitive to measure physiologically-important levels of ALP. There is an implication that HDL CH and the major HDL proteins may not relate directly to an important measure of CH metabolism or to AS risk. Finally, it has not been shown that raising HDL CH or apoprotein levels reduced AS risk, and should not be used for clinical prevention or treatment of AS without further study. Elevated levels of low-density lipoproteins, the major CH carrier in human plasma, have a clear-cut relation to AS risk. Lowering plasma CH with low-CH, low-saturated-fat diets lowers AS risk. (wz) 3

(PDF emailed within 0-6 h: $19.90)

Accession: 001085083

Download citation: RISBibTeXText

PMID: 7078610

DOI: 10.1056/NEJM198206243062509



Related references

High density lipoproteins and atherosclerosis III. Proceedings 3rd international symposium on plasma high density lipoproteins and atherosclerosis, San Antonio, 4-6 March, 1992. High density lipoproteins and atherosclerosis III Proceedings 3rd international symposium on plasma high density lipoproteins and atherosclerosis, San Antonio, 4-6 March, 1992: ix + 270 pp., 1992

International congress series 1001 high density lipoproteins and atherosclerosis iii 3rd international symposium on plasma high density lipoproteins and atherosclerosis san antonio texas usa march 4 6 1992. Miller, N E And A R Tall International Congress Series, No 1001 High Density Lipoproteins And Atherosclerosis, Iii; 3rd International Symposium on Plasma High Density Lipoproteins And Atherosclerosis, San Antonio, Texas, Usa, March 4-6, Ix+270p Elsevier Science Publishers B V : Amsterdam, Netherlands; New York, New York, Usa Illus Ix+270p, 1992

Atherosclerosis Reviews, Vol 24 High density lipoproteins Physiopathology and clinical relevance Second Bellagio Meeting on High Density Lipoproteins. Catapano, Alberico L , Bernini, Franco , Corsini, Alberto Atherosclerosis Reviews; High density lipoproteins: Physiopathology and clinical relevance XV+233P, 1993

The values of high-density lipoproteins and the risk of developing atherosclerosis. Salud Publica de Mexico 35(6): 637-641, 1993

The importance of cholesterol in high-density lipoproteins in determining risk for atherosclerosis. Vnitrni Lekarstvi 28(1): 15-22, 1982

Modulating effects of canine high density lipoproteins on cholesteryl ester synthesis induced by beta-very low density lipoproteins in macrophages. Possible in vitro correlates with atherosclerosis. Arteriosclerosis 2(2): 114-124, 1982

High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins: Relevance to regression of atherosclerosis?. Atherosclerosis 144(2): 367-374, June, 1999

Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis and Rheumatism 60(8): 2428-2437, 2009

The Becoming In Phylogenesis Of Transfer In Intercellular Medium And Active Absorption Of Polyenoic Fatty Acids By Cells Sequentially Of High Density Lipoproteins, Low Density Lipoproteins And High Density Apoe-Lipoproteins. Klinicheskaia Laboratornaia Diagnostika 60(6): 4-14, 2015

Lipoproteins in human atherosclerotic vessels. I. Biochemical properties of arterial low density lipoproteins, very low density lipoproteins, and high density lipoproteins. Experimental and Molecular Pathology 30(2): 144-171, 1979

Plasma distribution of cyclosporine within lipoproteins and "in vitro" transfer between very-low-density lipoproteins, low-density lipoproteins, and high-density lipoproteins. Therapeutic Drug Monitoring 13(4): 289-295, 1991

Effects of the callipyge phenotype on serum creatinine, total cholesterol, low-density lipoproteins, very-low-density lipoproteins, high-density lipoproteins, and triacylglycerol in growing lambs. Journal of Animal Science 74(7): 1548-1552, 1996

Controlled clinical trial of chloroquine in the serum levels of cholesterol , triglycerides , very low density lipoproteins , high density lipoproteins and low density lipoproteins in SLE patients. Arthritis & Rheumatism 42(9 SUPPL ): S148, Sept, 1999